Zoetis (ZTS) Treasury Shares (2013 - 2026)
Zoetis (ZTS) posted quarterly Treasury Shares of $11.3 billion for Q1 2026, up 2425.28% year-over-year from $447.0 million in Q1 2025, and up 5.64% quarter-over-quarter from $10.7 billion in Q4 2025.
Zoetis (ZTS) Treasury Shares (2013 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Treasury Shares for 12 consecutive years, with $11.3 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Treasury Shares rose 2425.28% year-over-year to $11.3 billion; the TTM figure through Mar 2026 stood at $11.3 billion (up 2425.28% YoY), while the FY2025 annual figure was $10.7 billion, up 43.52% from the prior year.
- Treasury Shares improved to $11.3 billion in Q1 2026 per ZTS's latest filing, from $10.7 billion in the prior quarter.
- Across five years, Treasury Shares topped out at $81.5 million in Q1 2026 and bottomed at $30.7 million in Q1 2022.
- Historically, Treasury Shares has averaged $49.0 million across 5 years, with a median of $44.9 million in 2024.
- Annual changes were most pronounced in 2023 — Treasury Shares tumbled 93.91% — and 2026, when it jumped 2425.28%.
- Zoetis' Treasury Shares stood at $4.5 billion in 2022, then advanced by 23.31% to $5.6 billion in 2023, then surged by 33.02% to $7.4 billion in 2024, then jumped by 43.52% to $10.7 billion in 2025, then advanced by 5.64% to $11.3 billion in 2026.
- Business Quant data shows ZTS's Treasury Shares at $11.3 billion in Q1 2026, $10.7 billion in Q4 2025, and $8.6 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 4.13 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 1.30 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -297.63 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 35.35 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 19.00 Mn |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | 502.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 87.74 Mn |
| Jun 30, 2026 | 11.85 Bn |
| Jun 30, 2026 | 11.85 Bn |
| Jun 30, 2026 | 87.74 Mn |
| Mar 31, 2026 | 11.29 Bn |
| Mar 31, 2026 | 11.29 Bn |
| Mar 31, 2026 | 81.54 Mn |
| Mar 31, 2026 | 81.54 Mn |
| Dec 31, 2025 | 76.96 Mn |
| Dec 31, 2025 | 76.96 Mn |
| Dec 31, 2025 | 10.69 Bn |
| Dec 31, 2025 | 10.69 Bn |
| Sep 30, 2025 | 8.61 Bn |
| Sep 30, 2025 | 60.43 Mn |
| Sep 30, 2025 | 60.43 Mn |
| Sep 30, 2025 | 8.61 Bn |
| Jun 30, 2025 | 57.90 Mn |
| Jun 30, 2025 | 57.90 Mn |
| Jun 30, 2025 | 8.23 Bn |
| Jun 30, 2025 | 8.23 Bn |